Nghiên cứu về sự phổ biến của HIV/AIDS ở Bangladesh và một số quốc gia đang phát triển khác

AIDS (2020) | Definition, Diagnosis, Treatment, & Facts | Britannica. Available at: https://www.britannica.com/science/AIDS Aids DCC (1999) HIV-1 RNA response to antiretroviral treatment in 1280 participants in the Delta Trial: an extended virology study. https://www.journals.lww.com Amazon.com (2013) Amazon.com: Gaia Herbs, Thyroid Support, Ashwaganda, Bladderwrack, Coleus, Kelp, Schisandra, Vegan Liquid Phyto Capsules, 120 Count: Health & Personal Care. Available at: https://www.amazon.com/Gaia-Herbs-Thyroid-Support-Capsules/dp/B00F1J8K2K Avila-Ríos S, García-Morales C, Garrido-Rodríguez D et al (2011) National prevalence and trends of hiv transmitted drug resistance in mexico. PLoS One 6(11) Azim T, Khan SI, Haseen F, Huq NL, Henning L, Pervez MM, Chowdhury ME, Sarafian I (2008) HIV and AIDS in Bangladesh. J Health Popul Nutr 26(3):311–324. https://doi.org/10.3329/jhpn.v26i3.1898 Azim T, Khan SI, Nahar Q et al (2009) 20 Years of HIV in Bangladesh World Bank, Washington, DC Baeten JM, Donnell D, Ndase P et al (2012) Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med 367(5): 399–410 Baker JV, Peng G, Rapkin J et al (2008) CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection. AIDS NIH Public Access 22(7):841–848 Bandura A (1990) Perceived self-efficacy in the exercise of control over AIDS infection. Eval Prog Plan Bangsberg D, Hecht F, Charlebois E et al (2000) Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. 14(4):356–366. https://www.journals.lww.com Barte-Sinoussi I, Popovic F, Samgadharan M et al (1983) The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. P. S. Proc. natiL Acad. Sci. U.S.A Beck EJ, Mandalia S, Leonard K et al (1996) Case-control study of sexually transmitted diseases as cofactors for HIV-1 transmission. Int J STD AIDS 7(1):34–38 Bloom DE, Canning D (2000) The Health and Wealth of Nations. 287(5456):1207–1209. https://www.science.sciencemag.org Bodsworth N (1989) The effect of concurrent human immunodeficiency virus infection on chronic hepatitis B: a study of 150 homosexual men. https://www.academic.oup.com Boerma J, Nunn A, JW A et al (1998) Mortality impact of the AIDS epidemic: evidence from community studies in less developed countries. 12:3–14. https://www.europepmc.org Bogart LM, Thorburn S (2005) Are HIV/AIDS conspiracy beliefs a barrier to HIV prevention among African Americans?. J Acquir Immune Defic Syndr Bontell I, Sarker MS, Rahman M et al (2013) Molecular dating of HIV-1 subtype C from Bangladesh. PLoS One 8(11): e79193 Brodt H, Kamps B, Gute P et al (1997) Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy. 11(14):1731–1738. https://www.journals.lww.com Centers for Disease Control and Preventation (2016) TB & HIV Coinfection | Basic TB Facts | TB | CDC. CDC. Available at: https://www.cdc.gov/tb/topic/basics/tbhivcoinfection.htm Centers for Disease Control and Prevention (2020) Prevention. Available from https://www.cdc.gov/hiv/basics/prevention.html Chaix M-L, Ekouevi K, Peytavin G et al (2006) Impact of NVP plasma concentration on selection of resistant virus in mothers who received sdNVP to prevent perinatal HIV-1 transmission and persistence of resistant virus in their infected children. Am Soc Microbiol Chase SK, Levine A (2016) A framework for evaluating and designing citizen science programs for natural resources monitoring. Conserv Biol 30(3):456–466 Coleman CL (2003) Spirituality and sexual orientation: Relationship to mental well-being and functional health status. J Adv Nurs 43(5):457–464 Coleman C, Holzemer WL (1999) Spirituality, psychological well-being, and HIV symptoms for African Americans living with HIV disease Colin JF, Cazals-Hatem D, Loriot MA et al (1999) Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology W.B. Saunders 29(4): 1306–1310 Cook JA, Grey D, Burke J et al (2004) Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women. Am J Public Health 94(7): 1133–1140 Cooper E, Charurat M, LM-JH et al (2002) Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1. J Acquir Immune Defic Syndr 29(5):484–494 Corbett EL, Watt CJ, Walker N et al (2003) The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med Am Med Assoc 163(9):1009–1021 Correll PK, Law MG, McDonald AM et al (1998) HIV disease progression in Australia in the time of combination antiretroviral therapies. Med J Aust 169(9): 469–472 Crepaz N, Lyles C, Wolitski R et al (2006) Do prevention interventions reduce HIV risk behaviours among people living with HIV? A meta-analytic review of controlled trials. 20(2):143–157. https://www.journals.lww.com Darbyshire JH (1996) Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected, Elsevier Dhaka Tribune (2018) HIV deaths: Bangladesh ranks 10th in Asia, India 1st. Available from https://www.dhakatribune.com/bangladesh/2018/01/26/hiv-aids-deaths-bangladesh-asia Dore G, Cooper D, Barrett C et al (1999) Dual efficacy of lamivudine treatment in human immunodeficiency virus/hepatitis B virus—Coinfected persons in a randomized, controlled study (CAESAR). 180(3):607–613. https://www.academic.oup.com Dubé K, Willenberg L, Dee L et al (2020) Re-examining the HIV ‘functional cure’ oxymoron: time for precise terminology?. J Virus Erad 6(4) Egger M, Hirschel B, Francioli P et al (1997) Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. 315 (7117):1194–1199. https://www.bmj.com Focus on six risk factors could prevent up to 80% of HIV infections in South African women (2010) | aidsmap. Available at:https://www.aidsmap.comnews/nov-2010/focus-six-risk-factors-could-prevent-80-hiv-infections-south-african-women Foster G, Germann S (2005) The orphan crisis. In: AIDS in Africa Kluwer Academic Publishers, pp. 664–75 Gallo R, Salahuddin S, M P et al (2020) Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. https://www.science.sciencemag.org Gallo RC, Montagnier L (2003) The Discovery of HIV as the Cause of AIDS. N Engl J Med 349(24): 2283–2285 Giesecke J, Scalia-Tomba G, Berglund O et al (1984) Incidence of symptoms and AIDS in 146 Swedish haemophiliacs and blood transfusion recipients infected with human immunodeficiency virus. 224(4648):500–503. https://www.bmj.com Gifford A, Bormann J, MS J et al (2000) Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. 23(5):386–395. https://www.europepmc.org Gilson R, Hawkins A, Beecham M et al (1997) Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection. 11(5):597–606. https://www.journals.lww.com Global HIV & AIDS statistics (2020) Fact sheet | UNAIDS. Available at: https://www.unaids.org/en/resources/fact-sheet Grigoryan A, Hall HI, Durant T et al (2009) Late HIV diagnosis and determinants of progression to AIDS or death after HIV diagnosis among injection drug users, 33 US States, 1996–2004. PLoS One 4(2) Hammer SM, Katzenstein DA, Hughes MD et al (1996) A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. N Engl J Med 335(15): 1081–1090 Hammer SM, Squires KE, Hughes MD et al (1997) A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med 337(11):725–733 Hanass-Hancock J (2009) Disability and HIV/AIDS—A systematic review of literature on Africa. J Int AIDS Soc Haubrich R, Little S, Currier J et al (1999) The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. 13(9):1099–1107. https://www.journals.lww.com HealthEd (2016) Preventing HIV infection. Available from https://www.healthed.govt.nz/resource/preventing-hiv-infection Hickman M, Bardsley M, Angelis D De et al (1999) Impact of HIV on adult (15–54) mortality in London: 1979–1996. 75(6):385–388. https://www.sti.bmj.com HIV and AIDS Symptoms NHS (2021) Available at: https://www.nhs.uk/conditions/hiv-and-aids/symptoms/ HIV/AIDS Diagnosis and Treatment Mayo Clinic (2020) Available at: https://www.mayoclinic.org/diseases-conditions/hiv-aids/diagnosis-treatment/drc-20373531 HIV/AIDS Symptoms and causes Mayo Clinic (2020) Available at: https://www.mayoclinic.org/diseases-conditions/hiv-aids/symptoms-causes/syc-20373524 HIV/AIDS (2021) Available at: https://www.who.int/news-room/fact-sheets/detail/hiv-aids HIV/AIDS Diagnosis (2020) | Stanford Health Care. Available at: https://stanfordhealthcare.org/medical-conditions/sexual-and-reproductive-health/hiv-aids/diagnosis.html Hl R, Gm C, Gw C et al (1989) Epidemiology of tuberculosis in the United States. Epidemiol Rev Oxford Univ Press 11(1):79–98 Hogg R, Heath K, Yip B et al (1998) Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. 279(6):450–444. https://www.jamanetwork.com https://www.theaidsinstitute.org, education, aids-101, how-can-hiv-be-prevented-0 (2020). https://www.theaidsinstitute.org/education/aids-101/how-can-hiv-be-prevented-0 Ickovics J, Hamburger M, Jama DV et al (2001) Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. 285(11):1466–1474. https://www.jamanetwork.com 21 Immune Boosting Foods, Tonics & Teas (2021) Goodness Me. Available at: https://goodnessme.ca/blogs/goodness-me/21-immune-boosting-foods-tonics-teas Islam M (2008) HIV and sexual risk behaviors among recognized high-risk groups in Bangladesh: need for a comprehensive prevention program. Elsevier Kellerman SE, Hanson DL, McNaghten AD et al (2003) Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects. J Infect Dis Khanam R, Hussain R, Minichiello V et al (2013) Migrant populations: socio-cultural dynamics and the explanation for the risk of HIV/AIDS transmission in Bangladesh Khosla N (2009) HIV/AIDS interventions in Bangladesh: what can application of a social exclusion framework tell us? J Health Popul Nutr BioMed Central 27(4):587 Koblin BA, Taylor PE, Rubinstein P et al (1992) Effect of duration of hepatitis B virus infection on the association between human immunodeficiency virus type-1 and hepatitis B viral replication. Hepatology 15(4):590–592 Lancet-CCT (1997) Randomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens for patients with HIV-1 infection: the CAESAR trial, Elsevier Lawn SD, Churchyard G (2009) Epidemiology of HIV-associated tuberculosis running head: epidemiology of TB /HIV. Curr Opin HIV AIDS Eur PMC Funders 4(4):325 Lesch A, Swartz L, Kagee A et al (2007) Paediatric HIV/AIDS disclosure: Towards a developmental and process-oriented approach. AIDS Care Leserman J, Golden RN, Perkins D (1999) Progression to AIDS: the effects of stress, depressive symptoms, and social support. https://www.journals.lww.com Levi GC, Antonio M, Vitó Ria A (2002) Fighting against AIDS: the Brazilian experience. 16(18):2373–2283. https://www.journals.lww.com Live Science (2019) AIDS & HIV: treatment & prevention. Available from https://www.livescience.com/34699-hiv-aids-symptoms-treament-prevention.html MacKellar DA, Valleroy LA, Secura GM et al (2005) Unrecognized HIV infection, risk behaviors, and perceptions of risk among young men who have sex with men. JAIDS J Acquir Immune Defic Syndr 38(5):603–614 Mahmood SAI (2010) TB and HIV/AIDS in Bangladesh. J AIDS HIV Res Acad J 2(4):66–78 Manzardo C, Londoño MC, Castells Ll et al (2018) Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: a prospective nationwide cohort study. Am J Transplant 18(10):2513–2522 Manzi M, Zachariah R, Teck R et al (2005) High acceptability of voluntary counselling and HIV-testing but unacceptable loss to follow up in a prevention of mother-to-child HIV transmission programme in rural Malawi: scaling-up requires a different way of acting. Wiley Online Libr 10(12):1242–1250 Marks G, Crepaz N, JS JJ (2005) Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. 39(4):446–453. https://www.journals.lww.com Mavragani A, Ochoa G (2018) Forecasting AIDS prevalence in the United States using online search traffic data. J Big Data 5(1) Mazroa MAA l., Kabbash IA, Felemban SM et al (2012) HIV case notification rates in the Kingdom of Saudi Arabia over the past decade (2000–2009). PLoS One 7(9):e45919 McKenzie JA (2013) Disabled people in rural South Africa talk about sexuality. Cult Health Sex 15(3):372–386 Mellors JW, Muñoz A, Giorgi JV et al (1997) Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med Am Coll Physicians 126(12):946–954 Millett GA, Peterson JL, Wolitski RJ et al (2006) Greater risk for HIV infection of black men who have sex with men: a critical literature review. Am J Public Health 96(6):1007–1019 Mocroft A, Vella S, Benfield T et al (1998) Changing patterns of mortality across Europe in patients infected with HIV-1, Elsevier 352(9142):1725–1730 Mondal NI, Islam R, Rahman O et al (2012) Determinants of HIV/AIDS awareness among garments workers in Dhaka City Bangladesh, Scientific Research Publishing 2012(04):312–318 Mouton Y, Alfandari S, Valette M et al (1997) Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres. 11(12):101–105. https://www.journals.lww.com Nunn A, Mulder D, Kamali A et al (1997) Mortality associated with HIV-1 infection over five years in a rural Ugandan population: cohort study. 315(7111):767–771. https://www.bmj.com Ockenga J, Tillmann H, Trautwein C et al (1997) Hepatitis B and C in HIV-infected patients: prevalence and prognostic value. Elsevier 27(1):18–24 Palella FJ, Delaney KM, Moorman AC et al (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 338(13):853–860 Paterson DL, Swindells S, Mohr J et al (2000) Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med Am Coll Physicians 133(1):21–30 Rinaldo C, Kingsley LA (1996) Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. https://www.science.sciencemag.org Saraceni V, King BS, Cavalcante SC et al (2008) Tuberculosis as primary cause of death among AIDS cases in Rio de Janeiro, Brazil International Union Against Tuberculosis and Lung Disease 12(7):769–772 Sarin E, Nayak H, Das M et al (2013) HIV testing among pregnant wives of migrant men in a rural district of India: urgent call for scale up. Women Health 53(4):369–383 Sekar R (2016) Global scenario of HIV/AIDS: Declining trend and moving toward cure. Indian J Public Health 60(1):59–63 Shaaban AN, Martins MRO (2019) The importance of improving the quality of care among HIV/AIDS hospitalizations in Portugal. Front in Pub Health 7:266 Siegfried N, Muller M, Deeks JJ et al (2009) Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst Rev Sultana N, Sharmin M, Muquith T et al (2021) HIV seroprevalence among the patients or clients obtaining blood sample at BSMMU virology laboratory. Eur J Clin Med 2(1):15–19 Summa V, Petrocchi A, Bonelli F et al (2008) Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection. J Med Chem 51(18):5843–5855 Surgery in Patients with HIV (2003) Available at: http://hivinsite.ucsf.edu/InSite?page=kb-00&doc=kb-03-03-02 Symptoms and stages of HIV infection (2020) | Avert. Available at: https://www.avert.org/about-hiv-aids/symptoms-stages Tapisiz OL (2020) The history of pandemics View project. researchgate.net Testori V, Adorni F, Castelnuovo B et al (1999) CD4 cell counts at the third month of HAART may predict clinical failure. 13(13):1669–1676. https://www.journals.lww.com Tewtrakul S, Subhadhirasakul S, Kummee S (2006) Anti-HIV-1 integrase activity of medicinal plants used as self medication by AIDS patients. 28(4):785–790. https://www.rdo.psu.ac.th The changing clinical epidemiology of AIDS in the highly act: AIDS (2002) Available at: https://journals.lww.com/aidsonline/fulltext/2002/16004/the_changing_clinical_epidemiology_of_aids_in_the.9.aspx Thio CL, Seaberg EC, Skolasky Jr R, Phair J, Visscher B, Muñoz A, Thomas DL (2002) HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet Thompson M, Aberg J Cahn P et al (2010) Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society–USA panel. jamanetwork.com Treating HIV/AIDS (2013) | Health24. Available at: https://www.news24.com/health24/Medical/HIV-AIDS/Overview/How-is-HIVAids-treated-20130205 Tropical MN-T of the RS (2006) Current issues in the prevention of mother-to-child transmission of HIV-1 infection. academic.oup.com UNICEF (2008) A political, managerial, and technical tool evaluation of the national health system response to HIV in the dominican republic pan american health organization santo domingo, Dominican Republic Urmi AZ, Leung DT, Wilkinson V et al (2015) Profile of an HIV testing and counseling unit in Bangladesh: majority of new diagnoses among returning migrant workers and spouses. PLoS One 10(10): e0141483 Vernazza PL, Troiani L, Flepp MJ et al (2000) Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. Lippincott Williams & Wilkins AIDS Vlahov D, Graham N, Hoover D et al (1998) Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: plasma viral load and CD4+ cell count. 279(1):35–40. https://www.jamanetwork.com Watkins WC (2014) Giving care to people with symptoms of AIDS in rural sub-Saharan Africa. AIDS Care—Psychol Socio-Medical Asp AIDS/HIV 16(7):795–807 What Are HIV and AIDS? (2020) | HIV.gov. Available at: https://www.hiv.gov/hiv-basics/overview/about-hiv-and-aids/what-are-hiv-and-aids Whitman S, Murphy J, Cohen M et al (2000) Marked declines in human immunodeficiency virus–related mortality in Chicago in women, African Americans, Hispanics, young adults, and injection drug users, from 1995 through 1997. Arch Intern Med 160(3):365–369. https://www.jamanetwork.com WIKIPEDIA THE FREE ENCYCLOPEDIA (2021) HIV/AIDS in Bangladesh. Available from https://en.wikipedia.org/wiki/HIV/AIDS_in_Bangladesh Wilkinson D, Connolly C, Aids KR et al (1999) Continued explosive rise in HIV prevalence among pregnant women in rural South Africa. 13(6):740. https://www.journals.lww.com Wilson KD, Dray-Spira R, Aubrière C et al (2014) Frequency and correlates of late presentation for HIV infection in France: older adults are a risk group—results from the ANRS-VESPA2 Study, France. AIDS Care 26 (SUPPL. 1): 83–93 World Health Organizatiom (2010) Co-management of HIV and active TB disease. World Health Organization Yi MS, Mrus JM, Wade TJ et al (2006) Religion, spirituality, and depressive symptoms in patients with HIV/AIDS 21(SUPPL. 5)